Urokinase inhibitors

Details Urokinase inhibitors Urokinase inhibitors

2011-08-23

2011-08-23

Shiao, Rei-tsang (Department: 1628)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Phosphorus containing other than solely as part of an...

C558S176000

Reexamination Certificate

active

08003627

ABSTRACT:
The present invention relates to novel compounds with inhibitory activity towards urokinase plasminogen activator (uPA); to methods for preparation of said uPA inhibitor compounds; to pharmaceutical compositions comprising said uPA inhibitor compounds; to the use of said uPA inhibitor compounds as a medicament and the use of said uPA inhibitor compounds for the preparation of a medicament for the treatment of conditions chosen from the group comprising cancer, tumour growth, tumour invasion, tumour metastasis, diabetic retinopathy, hemorrhagic atherosclerosis and inflammatory conditions, such as rheumatoid arthritis and psoriasis.

REFERENCES:
patent: 5952307 (1999-09-01), Powers et al.
patent: 7786098 (2010-08-01), Shen et al.
Cheruvallath et al., 2006, CAS: 144: 212913.
El Sayed et al., 2005, CAS: 142:447258.
Joossens et al., 2004, CAS: 141:7427.
Senten et al., 2003, CAS: 138:287948.
Hamilton et al., 1993, CAS: 120: 192271.
Powers et al., 1997, CAS: 128:3887.
Office Action for European Application No. EP 06 806 436.9, dated Jul. 30, 2009.
Joosens et al., “Development of Irreversible Diphenyl Phosphonate Inhibitors for Urokinase Plasminogen Activator,”J. Med. Chem. 47(10):2411-2413 (2004).
Joosens et al., “Diphenyl Phosphonate Inhibitors for the Urokinase-type Plasminogen Activator: Optimization of the P4 Position,”J. Med. Chem. 49(19):5785-5793 (2006).
Sienczyk and Oleksyszyn, “A Convenient Synthesis of New Alpha-Aminoalkylphosphonates, Aromatic Analogues of Arginine as Inhibitors of Trypsin-like Enzymes,”Tetrahedron Lett. 45(39):7251-7254 (2004).
Sienczyk and Oleksyszyn, “Inhibition of Trypsin and Urokinase by Cbz-amino(4-guanidino-phenyl)methanephosphonate Aromatic Ester Derivatives: The Influence of the Ester Group on their Biological Activity,”Bioorg. Med. Chem. Lett. 16(11):2886-2890 (2006).
International Preliminary Report on Patentability for International Application No. PCT/EP2006/010147, mailed Jan. 16, 2008.
International Search Report for International Application No. PCT/EP2006/010147, mailed Mar. 9, 2007.
Written Opinion of the International Searching Authority for International Application No. PCT/EP2006/010147, mailed Mar. 9, 2007.
Official Communication for European Patent Application No. 06 806 436.9, dated Feb. 2, 2010.
Dass et al., “Evolving Role of uPA/uPAR System in Human Cancers,”Cancer Treat. Rev. 1-15 (2007).
Duffy et al., “The Urokinase Plasminogen Activator System: A Rich Source of Tumor Markers for the Individualised Management of Patients with Cancer,”Clin. Biochem. 541-548 (2004).
EPO Communication inviting applicant to correct deficiencies found during examination of EP Application No. 06 806 436.9-2117 dated Jan. 18, 2011.
Hofmeister et al., “Anti-Cancer Therapies Targeting the Tumor Stroma,”Cancer Immunol. Immunother. 1-17 (2008).

Affiliated with

Also associated with

Rating

Urokinase inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Urokinase inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Urokinase inhibitors will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2734463